Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Receivables - Other: 2022-2024

Historic Receivables - Other for Amphastar Pharmaceuticals (AMPH) over the last 2 years, with Dec 2024 value amounting to $200,000.

  • Amphastar Pharmaceuticals' Receivables - Other rose 25.00% to $500,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $500,000, marking a year-over-year increase of 25.00%. This contributed to the annual value of $200,000 for FY2024, which is N/A change from last year.
  • Amphastar Pharmaceuticals' Receivables - Other amounted to $200,000 in FY2024, which was down 50.00% from $400,000 recorded in FY2022.
  • Amphastar Pharmaceuticals' Receivables - Other's 5-year high stood at $400,000 during FY2022, with a 5-year trough of $200,000 in FY2024.
  • Moreover, its 2-year median value for Receivables - Other was $300,000 (2022), whereas its average is $300,000.